- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05283811
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
July 17, 2025 updated by: Sameer Sheth, Baylor College of Medicine
Mapping Algorithmic State Space in the Human Brain
Humans have a remarkable ability to flexibly interact with the environment.
A compelling demonstration of this cognitive flexibility is human's ability to respond correctly to novel contextual situations on the first attempt, without prior rehearsal.
The investigators refer to this ability as 'ad hoc self-programming': 'ad hoc' because these new behavioral repertoires are cobbled together on the fly, based on immediate demand, and then discarded when no longer necessary; 'self-programming' because the brain has to configure itself appropriately based on task demands and some combination of prior experience and/or instruction.
The overall goal of our research effort is to understand the neurophysiological and computational basis for ad hoc self-programmed behavior.
The previous U01 project (NS 108923) focused on how these programs of action are initially created.
The results thus far have revealed tantalizing notions of how the brain represents these programs and navigates through the programs.
In this proposal, therefore, the investigators focus on the question of how these mental programs are executed.
Based on the preliminary findings and critical conceptual work, the investigators propose that the medial temporal lobe (MTL) and ventral prefrontal cortex (vPFC) creates representations of the critical elements of these mental programs, including concepts such as 'rules' and 'locations', to allow for effective navigation through the algorithm.
These data suggest the existence of an 'algorithmic state space' represented in medial temporal and prefrontal regions.
This proposal aims to understand the neurophysiological underpinnings of this algorithmic state space in humans.
By studying humans, the investigators will profit from our species' powerful capacity for generalization to understand how such state spaces are constructed.
The investigators therefore leverage the unique opportunities available in human neuroscience research to record from single cells and population-level signals, as well as to use intracranial stimulation for causal testing, to address this challenging problem.
In Aim 1 the investigators study the basic representations of algorithmic state space using a novel behavioral task that requires the immediate formation of unique plans of action.
Aim 2 directly compares representations of algorithmic state space to that of physical space by juxtaposing balanced versions of spatial and algorithmic tasks in a virtual reality (VR) environment.
Finally, in Aim 3, the investigators test hypotheses regarding interactions between vPFC and MTL using intracranial stimulation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
205
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sameer Sheth, MD, PhD
- Phone Number: 713-798-5060
- Email: sasheth@bcm.edu
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- Recruiting
- University of California, Los Angeles
-
Contact:
- Nanthia Suthana
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Baylor College of Medicine
-
Contact:
- Sameer A Sheth, MD, PhD
- Phone Number: 713-798-5060
- Email: sameer.sheth@bcm.edu
-
Contact:
- Victoria Pirtle
- Phone Number: 713-798-1717
- Email: victoria.pirtle@bcm.edu
-
Principal Investigator:
- Sameer A Sheth, MD, PhD
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Active, not recruiting
- University of Utah
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 64 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Eligible subjects include both male and female patients, between 10 years of age and 64 years of age, who undergo placement of intracranial electrodes for clinical characterization of epilepsy.
Exclusion Criteria:
- Grounds for exclusion would include inability to understand and follow instructions, or inability to concentrate sufficiently to achieve a high proportion of correct responses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Epilepsy Monitoring Unit
Patient's behavioral and neural activity via computer tasks and questionnaires are monitored in the Epilepsy Monitoring Unit
|
Patients are admitted to the Epilepsy Monitoring Unit for observation of seizure activity prior to further treatment
|
|
Other: Neuropace RNS Device
Patients are implanted with RNS device to treat their seizure activity
|
This device is indicated as a therapy in reducing the frequency of seizures in individuals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral performance (Accuracy as fraction of correct responses)
Time Frame: 7-14 days of behavioral performance collection
|
Patients will be asked to perform a few different novel, computerized tasks where the patients must respond to on-screen stimuli using button presses.
Behavior will be assessed in terms of the accuracy of these responses.
|
7-14 days of behavioral performance collection
|
|
Neurophysiological activity (single-neuron activity in spikes/second)
Time Frame: 7-14 days of neural activity collection
|
While patients are performing each behavioral task, the investigators will measure neural activity from BlackRock using depth electrodes with the aim of isolating single-neuron activity (for patients in the EMU) and local-field potential activity (for patients in the RNS patients).
Neurophysiological activity will be analyzed with the aim of understanding the neural representations underlying cognitive performance during the task.
|
7-14 days of neural activity collection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Estimated)
March 31, 2026
Study Completion (Estimated)
March 31, 2026
Study Registration Dates
First Submitted
February 28, 2022
First Submitted That Met QC Criteria
March 8, 2022
First Posted (Actual)
March 17, 2022
Study Record Updates
Last Update Posted (Actual)
July 20, 2025
Last Update Submitted That Met QC Criteria
July 17, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H18112
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
Clinical Trials on EMU
-
Cyberonics, Inc.CompletedEpilepsyUnited States
-
William Beaumont HospitalsTerminated